Moscow City Oncology Hospital №62-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2010

  1. Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort

    The Lancet, Vol. 375, Núm. 9712, pp. 377-384